This educational program consists of three presentations on the importance of early screening and the need for a multidisciplinary approach to identify patients at risk for CKD.

This course consists of the following:

• Barriers for preventing CKD in patients with diabetes - Prof. Christoph Wanner, MD – Würzburg, Germany
• Why is early screening and risk identification of CKD in diabetes important? - Rikke Borg, MD, PhD – Roskilde, Denmark
• Primary care as gatekeeper in CKD and the need for collaboration with nephrologists - Prof. Kamlesh Khunti, MD, PhD, Leister, UK

How to obtain your CME certificate

• Watch the three lectures and answer the pre- and post-test questions
• Fill in the evaluation questions
• Download CME Certificate (if your score >70%)

After watching these three videos, the learner should be able to:

• Describe CVD risk levels for CKD categories in the ESC 2021 guidelines on CVD prevention
• Identify who is at risk for CKD in patients with T2DM
• Tell how to identify those with high risk of CKD
• Define the challenge of management of patients with CKD
• Discuss details of an integrated care approach for improved CKD detection and management

Expert faculty

• Prof. Christoph Wanner, MD – Würzburg, Germany
• Rikke Borg, MD, PhD – Roskilde, Denmark
• Prof. Kamlesh Khunti, MD, PhD, Leister, UK

Target audience

This educational activity is designed for all healthcare professionals with an interest in management of patients at risk for CKD.

CME accreditation

This online course is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credit.

Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Funding

Funding for this educational program was provided by unrestricted educational grants from Boehringer Ingelheim and Lilly Alliance.

Questions

For questions regarding this activity, please contact us at info@pace-cme.org.